Email
Print
Gastroparesis Drugs Market - Forecast(2024 - 2030)
1. Gastroparesis Drugs Market - Overview
1.1 Definitions and Scope
2. Gastroparesis Drugs Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Gastroparesis Drugs Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Gastroparesis Drugs Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Gastroparesis Drugs Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Gastroparesis Drugs Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Gastroparesis Drugs Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Gastroparesis Drugs Market - By Drug Class (Market Size -$Million / $Billion)
8.1 Prokinetic Agent
8.2 Antiemetic Agent
8.3 Botulinum Toxin Injection
9. Gastroparesis Drugs Market - By Disease Type (Market Size -$Million / $Billion)
9.1 Diabetic Gastroparesis
9.2 Idiopathic Gastroparesis
9.3 Post-Surgical Gastroparesis
10. Gastroparesis Drugs - By Distribution Channel (Market Size -$Million / $Billion)
10.1 Hospital
10.2 Pharmacy
10.3 Clinic
1.1 Definitions and Scope
2. Gastroparesis Drugs Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Gastroparesis Drugs Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Gastroparesis Drugs Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Gastroparesis Drugs Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Gastroparesis Drugs Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Gastroparesis Drugs Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Gastroparesis Drugs Market - By Drug Class (Market Size -$Million / $Billion)
8.1 Prokinetic Agent
8.2 Antiemetic Agent
8.3 Botulinum Toxin Injection
9. Gastroparesis Drugs Market - By Disease Type (Market Size -$Million / $Billion)
9.1 Diabetic Gastroparesis
9.2 Idiopathic Gastroparesis
9.3 Post-Surgical Gastroparesis
10. Gastroparesis Drugs - By Distribution Channel (Market Size -$Million / $Billion)
10.1 Hospital
10.2 Pharmacy
10.3 Clinic
10.4 E-Commerce
11. Gastroparesis Drugs- By Geography (Market Size -$Million / $Billion)
11.1 Gastroparesis Drugs Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Gastroparesis Drugs- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Gastroparesis Drugs- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Gastroparesis Drugs - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Gastroparesis Drugs - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Gastroparesis Drugs Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Gastroparesis Drugs Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Gastroparesis Drugs Market - Key Company List by Country Premium
15. Gastroparesis Drugs Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Abbott Laboratory
15.3 Allergan Plc
15.4 Astrazeneca Plc
15.5 Cadila Pharmaceutical Limited
15.6 Etx Pharma, Inc
15.7 Evoke Pharma, Inc
15.8 Glaxosmithkline Plc
15.9 Neurogastrx, Inc
15.10 Theravance Biopharma, Inc
15.11 Valeant Pharmaceutical International, Inc
15.12 Company 12
15.13 Company 13 & More
16.1 Abbreviations
16.2 Sources
17. Gastroparesis Drugs Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
11. Gastroparesis Drugs- By Geography (Market Size -$Million / $Billion)
11.1 Gastroparesis Drugs Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Gastroparesis Drugs- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Gastroparesis Drugs- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Gastroparesis Drugs - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Gastroparesis Drugs - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Gastroparesis Drugs Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Gastroparesis Drugs Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Gastroparesis Drugs Market - Key Company List by Country Premium
15. Gastroparesis Drugs Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Abbott Laboratory
15.3 Allergan Plc
15.4 Astrazeneca Plc
15.5 Cadila Pharmaceutical Limited
15.6 Etx Pharma, Inc
15.7 Evoke Pharma, Inc
15.8 Glaxosmithkline Plc
15.9 Neurogastrx, Inc
15.10 Theravance Biopharma, Inc
15.11 Valeant Pharmaceutical International, Inc
15.12 Company 12
15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Gastroparesis Drugs Market - Appendix16.1 Abbreviations
16.2 Sources
17. Gastroparesis Drugs Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global Gastroparesis Drug Market, By Drug Class Market 2023-2030 ($M)1.1 Prokinetic Agent Market 2023-2030 ($M) - Global Industry Research
1.2 Antiemetic Agent Market 2023-2030 ($M) - Global Industry Research
1.3 Botulinum Toxin Injection Market 2023-2030 ($M) - Global Industry Research
2.Global Gastroparesis Drug Market, By Disease Type Market 2023-2030 ($M)
2.1 Diabetic Gastroparesis Market 2023-2030 ($M) - Global Industry Research
2.2 Idiopathic Gastroparesis Market 2023-2030 ($M) - Global Industry Research
2.3 Post-Surgical Gastroparesis Market 2023-2030 ($M) - Global Industry Research
3.Global Gastroparesis Drug Market, By Distribution Channel Market 2023-2030 ($M)
3.1 Hospital Market 2023-2030 ($M) - Global Industry Research
3.2 Pharmacy Market 2023-2030 ($M) - Global Industry Research
3.3 Clinic Market 2023-2030 ($M) - Global Industry Research
3.4 E-Commerce Market 2023-2030 ($M) - Global Industry Research
4.Global Gastroparesis Drug Market, By Drug Class Market 2023-2030 (Volume/Units)
4.1 Prokinetic Agent Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Antiemetic Agent Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Botulinum Toxin Injection Market 2023-2030 (Volume/Units) - Global Industry Research
5.Global Gastroparesis Drug Market, By Disease Type Market 2023-2030 (Volume/Units)
5.1 Diabetic Gastroparesis Market 2023-2030 (Volume/Units) - Global Industry Research
5.2 Idiopathic Gastroparesis Market 2023-2030 (Volume/Units) - Global Industry Research
5.3 Post-Surgical Gastroparesis Market 2023-2030 (Volume/Units) - Global Industry Research
6.Global Gastroparesis Drug Market, By Distribution Channel Market 2023-2030 (Volume/Units)
6.1 Hospital Market 2023-2030 (Volume/Units) - Global Industry Research
6.2 Pharmacy Market 2023-2030 (Volume/Units) - Global Industry Research
6.3 Clinic Market 2023-2030 (Volume/Units) - Global Industry Research
6.4 E-Commerce Market 2023-2030 (Volume/Units) - Global Industry Research
7.North America Gastroparesis Drug Market, By Drug Class Market 2023-2030 ($M)
7.1 Prokinetic Agent Market 2023-2030 ($M) - Regional Industry Research
7.2 Antiemetic Agent Market 2023-2030 ($M) - Regional Industry Research
7.3 Botulinum Toxin Injection Market 2023-2030 ($M) - Regional Industry Research
8.North America Gastroparesis Drug Market, By Disease Type Market 2023-2030 ($M)
8.1 Diabetic Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
8.2 Idiopathic Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
8.3 Post-Surgical Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
9.North America Gastroparesis Drug Market, By Distribution Channel Market 2023-2030 ($M)
9.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
9.2 Pharmacy Market 2023-2030 ($M) - Regional Industry Research
9.3 Clinic Market 2023-2030 ($M) - Regional Industry Research
9.4 E-Commerce Market 2023-2030 ($M) - Regional Industry Research
10.South America Gastroparesis Drug Market, By Drug Class Market 2023-2030 ($M)
10.1 Prokinetic Agent Market 2023-2030 ($M) - Regional Industry Research
10.2 Antiemetic Agent Market 2023-2030 ($M) - Regional Industry Research
10.3 Botulinum Toxin Injection Market 2023-2030 ($M) - Regional Industry Research
11.South America Gastroparesis Drug Market, By Disease Type Market 2023-2030 ($M)
11.1 Diabetic Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
11.2 Idiopathic Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
11.3 Post-Surgical Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
12.South America Gastroparesis Drug Market, By Distribution Channel Market 2023-2030 ($M)
12.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
12.2 Pharmacy Market 2023-2030 ($M) - Regional Industry Research
12.3 Clinic Market 2023-2030 ($M) - Regional Industry Research
12.4 E-Commerce Market 2023-2030 ($M) - Regional Industry Research
13.Europe Gastroparesis Drug Market, By Drug Class Market 2023-2030 ($M)
13.1 Prokinetic Agent Market 2023-2030 ($M) - Regional Industry Research
13.2 Antiemetic Agent Market 2023-2030 ($M) - Regional Industry Research
13.3 Botulinum Toxin Injection Market 2023-2030 ($M) - Regional Industry Research
14.Europe Gastroparesis Drug Market, By Disease Type Market 2023-2030 ($M)
14.1 Diabetic Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
14.2 Idiopathic Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
14.3 Post-Surgical Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
15.Europe Gastroparesis Drug Market, By Distribution Channel Market 2023-2030 ($M)
15.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
15.2 Pharmacy Market 2023-2030 ($M) - Regional Industry Research
15.3 Clinic Market 2023-2030 ($M) - Regional Industry Research
15.4 E-Commerce Market 2023-2030 ($M) - Regional Industry Research
16.APAC Gastroparesis Drug Market, By Drug Class Market 2023-2030 ($M)
16.1 Prokinetic Agent Market 2023-2030 ($M) - Regional Industry Research
16.2 Antiemetic Agent Market 2023-2030 ($M) - Regional Industry Research
16.3 Botulinum Toxin Injection Market 2023-2030 ($M) - Regional Industry Research
17.APAC Gastroparesis Drug Market, By Disease Type Market 2023-2030 ($M)
17.1 Diabetic Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
17.2 Idiopathic Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
17.3 Post-Surgical Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
18.APAC Gastroparesis Drug Market, By Distribution Channel Market 2023-2030 ($M)
18.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
18.2 Pharmacy Market 2023-2030 ($M) - Regional Industry Research
18.3 Clinic Market 2023-2030 ($M) - Regional Industry Research
18.4 E-Commerce Market 2023-2030 ($M) - Regional Industry Research
19.MENA Gastroparesis Drug Market, By Drug Class Market 2023-2030 ($M)
19.1 Prokinetic Agent Market 2023-2030 ($M) - Regional Industry Research
19.2 Antiemetic Agent Market 2023-2030 ($M) - Regional Industry Research
19.3 Botulinum Toxin Injection Market 2023-2030 ($M) - Regional Industry Research
20.MENA Gastroparesis Drug Market, By Disease Type Market 2023-2030 ($M)
20.1 Diabetic Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
20.2 Idiopathic Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
20.3 Post-Surgical Gastroparesis Market 2023-2030 ($M) - Regional Industry Research
21.MENA Gastroparesis Drug Market, By Distribution Channel Market 2023-2030 ($M)
21.1 Hospital Market 2023-2030 ($M) - Regional Industry Research
21.2 Pharmacy Market 2023-2030 ($M) - Regional Industry Research
21.3 Clinic Market 2023-2030 ($M) - Regional Industry Research
21.4 E-Commerce Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Gastroparesis Drugs Market Revenue, 2023-2030 ($M)2.Canada Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
3.Mexico Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
4.Brazil Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
5.Argentina Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
6.Peru Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
7.Colombia Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
8.Chile Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
9.Rest of South America Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
10.UK Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
11.Germany Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
12.France Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
13.Italy Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
14.Spain Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
15.Rest of Europe Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
16.China Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
17.India Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
18.Japan Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
19.South Korea Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
20.South Africa Gastroparesis Drugs Market Revenue, 2023-2030 ($M)
21.North America Gastroparesis Drugs By Application
22.South America Gastroparesis Drugs By Application
23.Europe Gastroparesis Drugs By Application
24.APAC Gastroparesis Drugs By Application
25.MENA Gastroparesis Drugs By Application
26.Abbott Laboratory, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Allergan Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Astrazeneca Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Cadila Pharmaceutical Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Etx Pharma, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Evoke Pharma, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Neurogastrx, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Theravance Biopharma, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Valeant Pharmaceutical International, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)